Tevogen Bio

Tevogen Bio's mission is to leverage our proprietary cell and gene therapy platform to innovate breakthrough and accessible immunotherapies for life-threatening cancers and viral infections with limited treatment options. Driven by a group of distinguished scientists and experienced biopharmaceutical leaders who have developed and commercialized multiple franchises, the company advanced its lead product from discovery to clinical stage within 12 months of its establishment, reducing the industry-standard drug development timeline by several years through collaborations with key strategic partners.